Skip to main content

Jane Huang

Equibles does not estimate personal net worth.

Get an email with a short summary when Protara Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TARA alerts

About Jane Huang

Jane Huang is recorded as Board Member at Protara Therapeutics, Inc. (TARA). The newest filing on record that lists Jane Huang as Board Member at Protara Therapeutics, Inc. (TARA) is dated April 28, 2026. The proxy statement of Prelude Therapeutics Inc reports total compensation of $1,438,904 for Jane Huang in fiscal 2024, including a base salary of $568,333. Disclosed compensation is on record for 4 fiscal years. Protara Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Protara Therapeutics, Inc. includes Jesse Shefferman (CEO and Board Member), Luke Beshar (Chairman), Blaine Davis (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Protara Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Prelude Therapeutics Inc (PRLD) $568,333 $1,438,904
2023 Prelude Therapeutics Inc (PRLD) $545,833 $1,654,662
2022 Prelude Therapeutics Inc (PRLD) $391,761 $2,920,215
2021 Prelude Therapeutics Inc (PRLD) — —

Recent activity

No call appearances or filed executive changes recorded yet.